The product is a new vaccine against COVID-19, for use in all adults 65 and older, as well as individuals aged 12-64 years.

The new vaccine is indicated for individuals who have been previously vaccinated with any COVID-19 vaccine and are 65 years or older, or 12 to 64 years of age with at least 1 underlying condition that ...

Rep. Marjorie Taylor Greene is sounding the alarm about a provision in the One Big Beautiful Bill Act that would restrict states from regulating artificial intelligence for a decade.

The findings underscore the need for continued surveillance to monitor the long-term dynamics of SARS-CoV-2 in deer and the ...

Two measles patients this week, a child from New Mexico and adult from Minnesota, contracted the virus on domestic flights.

With U.S. recommendations for COVID-19 vaccines in flux, a leading member of the CDC's COVID vaccine advisory group is ...

Axsome (AXSM) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.